PAVmed Inc.
PAVM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001624326
No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding PAVmed Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 32 | 36 | +4 |
| Shares | 1.26M | 1.61M | +353.4K (+28.1%) |
| Value | $755.8K | $677.4K | −$78.4K (−10.4%) |
New holders (6)
Institutions that held PAVmed Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 38,974 | $17.0K | 0.00% |
| XTX Topco Ltd | 12,303 | $5.33K | 0.00% |
| Barclays PLC | 69 | $29 | 0.00% |
| Binnacle Investments Inc | 67 | $29 | 0.00% |
| Citigroup Inc | 38 | $16 | 0.00% |
| Summit Wealth Group LLC | 43,017 | – | – |
Sold out (2)
Institutions that held PAVmed Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Raymond James Financial Inc | 2,481 | $1.49K |
| Mount Yale Investment Advisors, LLC | 34 | $20 |